Healthcare

China says Nvidia broke antimonopoly laws, health plan subsidies in play, bank merger market heats up, and more news to start your day.

Subsidies that made the marketplace plans more affordable are set to expire. Some lawmakers are trying to get them back.

Multiple outlets reported that Food and Drug Administration officials plan to make the case next week that the Covid-19 shots are linked to the deaths of 25 children.

For U.S. Big Pharma companies, vaccines have largely been an afterthought. But by 2030, they could be a quarter of Pfizer’s revenue.

The tests look for bits of altered DNA that cancer cells shed into the bloodstream. The screening technology holds hope of finding cancers early, when they might be cured.

Oracle trades lower following the stock’s 36% jump on Wednesday.

The shares’ gain reflects the extraordinary level of anxiety that has overshadowed managed-care stocks in recent months.

Morgan Stanley analysts left discussions with top executives more positive about the outlook, the bank said.

The weight-loss drugs company also slashed its profit guidance for the second time in six weeks.

Higher ratings bring bonus payments that amount to billions of dollars a year.

Oracle’s cloud outlook wows investors, judge temporarily blocks Trump from firing Fed’s Cook, turf war erupting over Fannie and Freddie, and more news to start your day.

Some healthcare names are flashing technical buy signals.

Some half a million cases of Lyme disease occur each year in the U.S., plus another 130,000 in Europe.

Apple shares slip as the tech company unveils several new iPhones at its annual launch event.

Today’s announcement should be a reassuring sign that the new management team may be getting things back on track.

Novartis agrees to acquire Tourmaline Bio in an all-cash deal worth around $1.4 billion.

Echostar’s spectrum sale, StubHub revives IPO plans, Pfizer says new Covid shots are effective, and more news to start your day.

Acetaminophen, the active ingredient in Tylenol, is one of the few pain relief and fever reduction medicines recommended for pregnant women.

The healthcare sector is up 6% since early August, but is still cheap. And it’s got more room to run.

The health secretary is testifying Thursday morning on his agenda before the committee.

The state initiated a position in two European banks during the second quarter.

Back-to-school spending is strong, and other revelations from RBC’s reading of S&P 500 earnings-call transcripts. Plus, investment newsletter commentary on interest rates, agriculture, and healthcare stocks.

The economy ministry blamed the slowdown on U.S. tariffs, but faltering demand for Ozempic and Wegovy could be another factor.

Healthcare, financials, industrials, and small-caps are on many shopping lists. But not the Magnificent Seven.

They’re bargains right now, according to two key measures. Expert Jim Paulsen won’t venture a guess when the prices will recover.